scispace - formally typeset
K

Knut Dietzmann

Researcher at Otto-von-Guericke University Magdeburg

Publications -  73
Citations -  2283

Knut Dietzmann is an academic researcher from Otto-von-Guericke University Magdeburg. The author has contributed to research in topics: Glioma & PTEN. The author has an hindex of 27, co-authored 73 publications receiving 2165 citations.

Papers
More filters
Journal ArticleDOI

Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse

TL;DR: The data strongly suggest that a specific decrease in the amount of all mitochondrial inner membrane enzymes, most probably as result of Ca2+ overload of muscle fibers, is the reason for the bioenergetic deficits in dystrophin-deficient skeletal muscle.
Journal Article

Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.

TL;DR: The frequent overexpression of the sst2A receptor may explain the high tracer uptake often observed in meningioma patients during somatostatin receptor scintigraphy and this simple immunohistochemical method could prove useful in identifying those cases of recurrent disease that may possibly respond to therapy with sst 2-selective agonists.
Journal ArticleDOI

High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples.

TL;DR: The data suggest that the same mechanisms that generate inherited mtDNA polymorphisms are strongly enhanced in gliomas and produce somatic mutations.
Journal ArticleDOI

Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas

TL;DR: Both MAPK and PI3K/Akt pathways are activated at different levels in benign and malignant meningiomas, whereas MAPK activation is involved in both proliferation and apoptosis of malignant males.
Journal ArticleDOI

Increased human polo-like kinase-1 expression in gliomas.

TL;DR: PLK-mRNA, found in all tumour specimens investigated emphasizes the close correlation to proliferation and growth and there was a significant correlation between the PLK expression and the nuclear immunoreactivity of MIB-1.